Research analysts who have asked questions during Docebo earnings calls.
George Sutton
Craig-Hallum
4 questions for DCBO
Josh Baer
Morgan Stanley
4 questions for DCBO
Robert Young
Canaccord Genuity
4 questions for DCBO
Suthan Sukumar
Stifel Financial Corp.
4 questions for DCBO
Kevin Krishnaratne
Scotiabank
3 questions for DCBO
Richard Tse
National Bank Financial
3 questions for DCBO
Yi Fu Lee
Cantor Fitzgerald
3 questions for DCBO
Erin Kyle
CIBC World Markets
2 questions for DCBO
Gavin Fairweather
BMO Capital Markets
2 questions for DCBO
Matthew Shea
Needham & Company
2 questions for DCBO
Ryan MacDonald
Needham & Company
2 questions for DCBO
Stephanie Price
CIBC World Markets
2 questions for DCBO
Daniel Chan
TD Cowen
1 question for DCBO
Kevin Kumar
Goldman Sachs
1 question for DCBO
Kiran Sritharan
Eight Capital
1 question for DCBO
Martin Toner
ATB Capital Markets
1 question for DCBO
Recent press releases and 8-K filings for DCBO.
- Docebo reported 14% year-over-year ARR growth excluding the Dayforce business for Q3 2025, marking the second consecutive quarter of this growth.
- The company achieved a 20% EBITDA margin in Q3 2025, earlier than expected, with a mid-term goal of reaching 25% margin through G&A leverage.
- Docebo secured two new federal customers shortly after its May-dated FedRAMP listing, including an expanded account with the Department of Energy and the Air Force Cyber Academy, exceeding initial expectations for federal business wins.
- The Dayforce OEM contract is winding down faster than anticipated, projected to represent 3.5-4.5% of total revenues in 2026 and 1-2% in 2027, impacting overall customer counts but improving Average Contract Value (ACV).
- Docebo reported Q3 2025 total revenue of $61.6 million, an 11% increase from the prior year, with subscription revenue growing 10% to $58.0 million.
- Net income for Q3 2025 was $6.1 million ($0.21 per share), and Adjusted EBITDA reached $12.4 million, representing 20.1% of total revenue.
- Annual Recurring Revenue (ARR) increased by 10.1% to $235.6 million as of September 30, 2025.
- The company provided Q4 2025 total revenue guidance between $62.0 million and $62.2 million and FY 2025 total revenue growth guidance of 11.40%.
- Working Capital decreased to $5.6 million as of September 30, 2025, from $9.9 million in the prior year, primarily due to cash used for share repurchases.
- Docebo reported strong financial results for Q3 2025, with total revenue increasing 11% to $61.6 million and subscription revenue growing 10% to $58.0 million.
- For Q3 2025, the company achieved net income of $6.1 million ($0.21 per share) and Adjusted Net Income of $9.9 million ($0.34 per share).
- Annual Recurring Revenue (ARR) stood at $235.6 million as of September 30, 2025, representing a 10.1% increase from the comparative period in the prior year.
- Docebo provided financial guidance for Q4 2025, expecting total revenue between $62.0 million and $62.2 million and Adjusted EBITDA as a percentage of total revenue between 20.5% to 21.0%.
- The company revised its fiscal year 2025 guidance, forecasting total revenue growth of 11.40% and subscription revenue growth of 11.75%.
Quarterly earnings call transcripts for Docebo.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more